BayWa's Restructuring Meets Legal and Financial Crossfire

BayWa battles shareholder lawsuits, regulatory probes, and a stalled €4bn debt reduction plan as asset sales falter and key refinancing deadlines loom.

The pressure on German agricultural and energy group BayWa is intensifying on multiple fronts. While management scrambles to secure its financial future through asset sales, a new wave of shareholder litigation and regulatory scrutiny threatens to further complicate an already precarious restructuring. The company's shares, trading at €13.80, have fallen roughly 17.6% since the start of the year, reflecting deep market unease.

This legal dimension adds a critical layer of complexity. Following an official reprimand from German financial watchdog BaFin, law firm TILP is preparing a collective action lawsuit against BayWa. The BaFin found that the company's 2023 annual report omitted crucial details regarding a multi-billion euro loan and specific refinancing risks tied to a €500 million bond. Investors who purchased shares between January 2022 and mid-January 2026 may now seek damages.

The scrutiny extends beyond the company's management. Auditor PwC, which issued an unqualified audit opinion for 2023 without highlighting existential risks, is also in the crosshairs. As a direct consequence of the accounting crisis, BayWa will part ways with PwC starting in 2026 and is currently reviewing potential claims against the auditor. In a separate proceeding, the Munich I public prosecutor's office is investigating former CEOs Klaus Josef Lutz and Marcus Pöllinger on suspicion of breach of trust and the deliberate misrepresentation of liquidity risks.

Amid this legal storm, the core financial restructuring is struggling to gain traction. The company's survival plan requires reducing debt by a total of €4 billion by 2028. So far, asset disposals have secured only €1.3 billion in debt relief. A major setback was the effective collapse of the planned sale of a 51% stake in its renewable energy unit, BayWa r.e., which was originally valued at up to €1.7 billion. The deal faltered after anticipated US subsidies for renewable energy were scrapped, causing the unit's valuation to plummet.

Management is now pursuing a "Plan B," focusing on the sale of its 74% stake in New Zealand fruit trader T&G Global. The US investment bank Goldman Sachs has been mandated to handle the sale, with analysts estimating proceeds of around €300 million. A more immediate, though smaller, cash injection of €45 million is expected by the end of April from the completed sale of Dutch subsidiary Cefetra.

Operational cuts are running in parallel. The company plans to eliminate 1,300 jobs by 2027 and permanently close 26 branches. Furthermore, the supervisory board has drastically lowered the approval threshold for business deals from €200 million to €50 million to exert greater control—a move directly linked to the ongoing governance investigations.

The entire process is now approaching a critical bottleneck. The consent of creditor banks DZ Bank and HVB to extend a standstill agreement until autumn 2026 is absolutely essential to buy the company the necessary time. Investors, however, are being forced to navigate in the dark. Due to the complex revaluation of subsidiaries, notably the energy unit, the audited group financial statements for 2025 are not expected until the fourth quarter of 2026. This lack of reliable fundamental data leaves shareholders evaluating the stock against a backdrop of mounting legal jeopardy, ongoing asset sales, and unresolved creditor negotiations.